Emerging Trade Pacts Offer Opportunities In Face Of DRG Payment Woes – Ubl
This article was originally published in The Gray Sheet
Executive Summary
Central America and some Asian countries provide emerging overseas growth areas for device manufacturers, according to AdvaMed Exec VP-Federal Government Relations Steve Ubl
You may also be interested in...
Japanese Price Revision Cycle Yields Progress Amidst Obstinacy – AdvaMed
U.S. device industry reps expect Japanese "R-zone" price cuts to more closely approximate market conditions than foreign average pricing (FAP) revisions
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.